@NebraskaMed & @MemorialHermann are expanding partnerships to launch Helix Genomic Advantage™ — integrating clinical-grade genomic insights into care for targeted populations.
This marks the second and third health systems in the country to adopt Helix Genomic Advantage, following St. Luke’s University Health Network. These organizations are helping expand access to precision medicine through genomics-informed care.
Read more: https://t.co/yP9ATXEMLH
#Genomics #PrecisionMedicine
Genomics is the future of care, but collaboration is how we get there. Hear how health systems in the Helix Research Network are sharing insights to elevate patient outcomes. 🧬 https://t.co/ICN3vA8DVP
Helix GenoSphere™ has surpassed 500,000 clinico-genomic records, making it one of the largest available linked clinico-genomic datasets in the world.
We're also launching Cohort Builder, the first of our new AI-powered tools designed to accelerate data exploration and analysis.
Read more: https://t.co/3wQ59uJoHI
Expanding access can reshape outcomes and engagement. Helix Genomic Advantage enables broader access to genetic testing as a health plan benefit, supporting precision health goals and strengthening the patient experience.
WATCH: https://t.co/OPBt8jEiek
@mystlukes is the first health system in the country to launch Helix Genomic Advantage™ – our new genomic benefit that drives access to precision medicine and reduces total medical cost.
Read more: https://t.co/jfLxofhWjX #PrecisionMedicine#Genomics 🧬
Join us this Friday for a deep dive into how St. Luke’s University Health Network transitioned from a precision medicine vision to true market leadership.
We’re moving past fragmented care to show how executive alignment and strategic partnership drive measurable growth and community impact.
Key Insights:
The Business Case: Elevating genomics to a board-level priority.
Faster Execution: Avoiding adoption barriers through a unified partnership structure.
Cultural Shift: The power of patient stories in transforming organizational morale.
📆 Friday, March 27 | 1:00 PM – 2:00 PM ET
Speakers:
Aldo Carmona, MD (St. Luke’s University Health Network)
Cassie Hajek, MD (Helix Research Network)
Moderator: Craig Newman (Helix)
👉 Register: https://t.co/QCzpA9r7Rl
#PrecisionMedicine #HealthcareStrategy #HealthSystems #Genomics #StLukes #Helix
Game-changing results from our academic health system partner's precision medicine program:
66,000 patients sequenced
~1,000 hereditary condition findings
And it's still growing
After three years, the results are in:
-> 1-week PGx turnaround reduced to just 80 seconds with SOQO
-> 9% of patients new to the health system
-> 20% of unengaged participants re-engaged
-> $13.5M in grant funding potential through genomic dataset
This is the power of precision medicine. Every data point compounds, driving real clinical impact.
What's your most impressive precision medicine outcome? Share with us!
#PrecisionMedicine #Genomics #HealthcareInnovation #HealthSystems #PopulationHealth
We listened to our health system partners and built the Helix Genetic Risk Assessment in just 6 weeks. This digital workflow streamlines patient eligibility, consent, and ordering for genetic testing, reducing clinical time and improving patient care. Interested in a demo? Comment 'demo' or send us a note. #GeneticTesting #HealthcareInnovation #PrecisionMedicine #Helix
Excited to announce our multi-year agreement with @Alnylam!
This agreement will aim to accelerate precision medicine development and transform drug
discovery across major therapeutic areas.
Learn More: https://t.co/tTYwTCWtqC
We’re excited to share that James Lu, MD, PhD, co-founder & CEO of Helix, will be speaking at #ViVE2026 in LA next Tuesday! 🧬
James will discuss what it takes to turn genomic data into real-time, actionable insights.
Learn more and register here: https://t.co/bpBjb9zNph
#ViVEvent
Excited to announce our partnership with @MawiDNA!
We’re expanding access to non-invasive genomic sample collection with buccal swab technology to increase flexibility and participation across diverse populations.
Learn more: https://t.co/JrZehI9g9b
🏆 Helix was awarded a BIG Innovation Award!
This recognition highlights our leadership in transforming healthcare through enterprise genomics and driving precision medicine at scale. 🧬 Learn more: https://t.co/gNvcdlJxCw @BigAwards
Excited to announce our multi-year collaboration with @GSKUS! 🧬
This partnership will aim to accelerate precision medicine development and transform drug
Learn more: https://t.co/1JWawBk7Gt
🎊 Thrilled to announce Helix has been named one of @GenomeWeb's Best Places to Work (101-250 employee category)! 🏅
Grateful for our incredible team who make Helix not just a workplace, but a community driving innovation in genomics.
https://t.co/xIzkfInH1S
#BestPlacesToWork
Proud to partner with @UHN on one of Canada's largest population genomics studies.
Today, few cancer patients receive genetic testing. Universal screening programs change that.
Learn more: https://t.co/GT2VmdLvO5
New study by Helix team in @JAHA_AHA showcases impact of genomic screening for Familial Hypercholesterolemia:
• 1 in 198 identified with FH
• 84% previously undiagnosed
Helix advancing preventive healthcare through genomics! 🧬❤️
🔗 https://t.co/XiqZlkXBFT
#GenomicMedicine#FH
Yesterday, @ROCRegional held a groundbreaking media event to unveil GenoWell, their new no-cost genetic screening program in partnership with @my_helix This marks a significant step towards precision medicine in the Rochester area! https://t.co/K0LrHfLx4T #GeneticScreening
#HLTH2025, Helix CEO Dr. James Lu joined a panel discussion called "Your DNA's Digital Twin," that explored the cutting-edge advancements in decoding the complexities of DNA: https://t.co/tfq4n47shK
#PrecisionMedicine#HeliхDNA
Helix's Liz Cirulli presented: "Hypercholesterolemia polygenic score modulates response to statin therapy"
New insights on Statin treatment & effectiveness! Stop by Booth #2074 today at 12pm ET to meet Dr. Cirulli and learn more! #HelixResearch#PrecisionMedicine#ASHG2025
🚀 Thrilled to announce: Helix is a finalist in the 2025 Fierce Innovation Awards - Life Sciences Edition!
🏆 Category: Data Analytics/Business Intelligence
More info: https://t.co/qJpQNROp4T
#FierceInnovationAwards#LifeSciences